ARCHIVES

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Center Directors Solidly opposed To Core grant changes, Ask Upton, NCAB To Find Other Solutions

November 11, 1977

Central Line Safety Intervention Lowers Patient Infection Rate

October 25, 2013

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

June 29, 2012

NCI Advisors Approve New Grant Program In Bone Metastasis

April 5, 2002

Cooney to Oversee University of Michigan Clinical Operations

February 7, 2013

First Round Of Cooperative Group Mergers Falls Short Of NCI’s Stated Goal

February 4, 2011